Business News : RBC Capital Raises ICPT to $500 Target LINK
Intercept Pharmaceuticals PT Raised to $500.00 at RBC Capital (ICPT)
August 12th, 2014 • 0 comments • Filed Under • by ABMN Staff
Share on StockTwits
Intercept Pharmaceuticals Inc logoStock analysts at RBC Capital raised their price target on shares of Intercept Pharmaceuticals (NASDAQ:ICPT) from $425.00 to $500.00 in a report issued on Tuesday. The firm curently has an “outperform” rating on the stock.